363 related articles for article (PubMed ID: 20631058)
1. The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer.
Kodach LL; Jacobs RJ; Heijmans J; van Noesel CJ; Langers AM; Verspaget HW; Hommes DW; Offerhaus GJ; van den Brink GR; Hardwick JC
Carcinogenesis; 2010 Sep; 31(9):1567-75. PubMed ID: 20631058
[TBL] [Abstract][Full Text] [Related]
2. Enhancer of zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation.
Fujii S; Ito K; Ito Y; Ochiai A
J Biol Chem; 2008 Jun; 283(25):17324-32. PubMed ID: 18430739
[TBL] [Abstract][Full Text] [Related]
3. EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR.
Wang C; Liu Z; Woo CW; Li Z; Wang L; Wei JS; Marquez VE; Bates SE; Jin Q; Khan J; Ge K; Thiele CJ
Cancer Res; 2012 Jan; 72(1):315-24. PubMed ID: 22068036
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the expression of claudin 23 by the enhancer of zeste 2 polycomb group protein in colorectal cancer.
Maryan N; Statkiewicz M; Mikula M; Goryca K; Paziewska A; Strzałkowska A; Dabrowska M; Bujko M; Ostrowski J
Mol Med Rep; 2015 Jul; 12(1):728-36. PubMed ID: 25695204
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic changes induced by oxidative stress in colorectal cancer cells: methylation of tumor suppressor RUNX3.
Kang KA; Zhang R; Kim GY; Bae SC; Hyun JW
Tumour Biol; 2012 Apr; 33(2):403-12. PubMed ID: 22274925
[TBL] [Abstract][Full Text] [Related]
6. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation.
Kondo Y; Shen L; Cheng AS; Ahmed S; Boumber Y; Charo C; Yamochi T; Urano T; Furukawa K; Kwabi-Addo B; Gold DL; Sekido Y; Huang TH; Issa JP
Nat Genet; 2008 Jun; 40(6):741-50. PubMed ID: 18488029
[TBL] [Abstract][Full Text] [Related]
7. Demethylation of RUNX3 by vincristine in colorectal adenocarcinoma cells.
Moon JW; Lee SK; Lee JO; Kim JH; Kim N; Kim J; Kim HS; Park SH
Anticancer Res; 2014 Jan; 34(1):133-40. PubMed ID: 24403453
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
Chen W; Gao N; Shen Y; Cen JN
J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
[TBL] [Abstract][Full Text] [Related]
9. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
Lee SH; Kim J; Kim WH; Lee YM
Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress induces proliferation of colorectal cancer cells by inhibiting RUNX3 and activating the Akt signaling pathway.
Kang KA; Kim KC; Bae SC; Hyun JW
Int J Oncol; 2013 Nov; 43(5):1511-6. PubMed ID: 24042352
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic repression of SATB1 by polycomb group protein EZH2 in epithelial cells.
Lei L; Lu L; Xiang L; Xue-song W; De-pei L; Chih-chuan L
Chin Med Sci J; 2010 Dec; 25(4):199-205. PubMed ID: 21232178
[TBL] [Abstract][Full Text] [Related]
12. Enhancer of zeste homolog 2 downregulates E-cadherin by mediating histone H3 methylation in gastric cancer cells.
Fujii S; Ochiai A
Cancer Sci; 2008 Apr; 99(4):738-46. PubMed ID: 18377425
[TBL] [Abstract][Full Text] [Related]
13. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
14. Silencing of MBD2 and EZH2 inhibits the proliferation of colorectal carcinoma cells by rescuing the expression of SFRP.
Xie Y; Wang F; Yu J; Zhang J; Liu Y; Li M; Qi J
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34617573
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of Ezh2 methyltransferase by FOXP3: new insight of FOXP3 into chromatin remodeling?
Shen Z; Chen L; Yang X; Zhao Y; Pier E; Zhang X; Yang X; Xiong Y
Biochim Biophys Acta; 2013 Oct; 1833(10):2190-200. PubMed ID: 23688634
[TBL] [Abstract][Full Text] [Related]
16. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
[No Abstract] [Full Text] [Related]
17. A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis.
Coward WR; Feghali-Bostwick CA; Jenkins G; Knox AJ; Pang L
FASEB J; 2014 Jul; 28(7):3183-96. PubMed ID: 24652950
[TBL] [Abstract][Full Text] [Related]
18. BCL2L10 is frequently silenced by promoter hypermethylation in gastric cancer.
Mikata R; Fukai K; Imazeki F; Arai M; Fujiwara K; Yonemitsu Y; Zhang K; Nabeya Y; Ochiai T; Yokosuka O
Oncol Rep; 2010 Jun; 23(6):1701-8. PubMed ID: 20428828
[TBL] [Abstract][Full Text] [Related]
19. Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells.
Sun F; Chan E; Wu Z; Yang X; Marquez VE; Yu Q
Mol Cancer Ther; 2009 Dec; 8(12):3191-202. PubMed ID: 19934278
[TBL] [Abstract][Full Text] [Related]
20. Investigation of transcriptional gene silencing and mechanism induced by shRNAs targeted to RUNX3 in vitro.
Feng XZ; He XS; Zhuang YZ; Luo Q; Jiang JH; Yang S; Tang XF; Liu JL; Chen T
World J Gastroenterol; 2008 May; 14(19):3006-14. PubMed ID: 18494051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
